Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced a licensing agreement with Jiangsu Alphamab Biopharmaceuticals Co., Ltd.
EPISD welcomes thousands of students back to district schools.
The coalition of states sued in federal court in Washington to stop the agency that controls the program from moving ahead ...